Intercept Pharmaceuticals, Inc.

PINNACLE ASSOCIATES LTD

Report date

9/30/2023

Quarter

2023 Q3

Filed

10/24/2023

Shares

197,237

Value ($000)

3,657

Weight

0.1%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	10/24/2023	3,657	0.1%	197,237	9/30/2023
2023 Q2	7/27/2023	2,213	0.0%	200,119	6/30/2023
2023 Q1	5/5/2023	2,804	0.1%	208,799	3/31/2023
2022 Q4	2/1/2023	2,564	0.1%	207,273	12/31/2022
2022 Q3	11/1/2022	2,965	0.1%	212,548	9/30/2022
2022 Q2	8/2/2022	1,571	0.0%	113,770	6/30/2022
2022 Q1	5/5/2022	1,863	0.0%	114,494	3/31/2022
2021 Q4	2/2/2022	1,932	0.0%	118,604	12/31/2021
2021 Q3	10/19/2021	1,794	0.0%	120,805	9/30/2021
2021 Q2	8/2/2021	2,456	0.0%	122,960	6/30/2021
2021 Q1	5/12/2021	2,775	0.1%	120,218	3/31/2021
2020 Q4	1/26/2021	3,306	0.1%	133,828	12/31/2020
2020 Q3	10/23/2020	5,913	0.1%	142,612	9/30/2020
2020 Q2	8/14/2020	7,083	0.2%	147,832	6/30/2020
2020 Q1	5/13/2020	9,470	0.3%	150,412	3/31/2020
2019 Q4	2/3/2020	21,598	0.5%	174,293	12/31/2019